| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
AFX Stock Overview
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally.
Rewards
Risk Analysis
No risks detected for AFX from our risk checks.
Carl Zeiss Meditec Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €142.05 |
| 52 Week High | €202.00 |
| 52 Week Low | €119.50 |
| Beta | 0.36 |
| 1 Month Change | -22.38% |
| 3 Month Change | -16.61% |
| 1 Year Change | 8.35% |
| 3 Year Change | 80.84% |
| 5 Year Change | 302.47% |
| Change since IPO | 305.86% |
Recent News & Updates
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger
There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...
If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Shareholder Returns
| AFX | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.6% | 0.9% | -2.0% |
| 1Y | 8.4% | 24.4% | 8.1% |
Return vs Industry: AFX underperformed the German Medical Equipment industry which returned 27.6% over the past year.
Return vs Market: AFX underperformed the German Market which returned 10% over the past year.
Price Volatility
| AFX volatility | |
|---|---|
| AFX Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 9.7% |
| 10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: AFX is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: AFX's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1846 | 3,531 | n/a | https://www.zeiss.de/meditec-ag/home.html |
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.
Carl Zeiss Meditec Fundamentals Summary
| AFX fundamental statistics | |
|---|---|
| Market Cap | €12.71b |
| Earnings (TTM) | €236.28m |
| Revenue (TTM) | €1.65b |
53.8x
P/E Ratio7.7x
P/S RatioIs AFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFX income statement (TTM) | |
|---|---|
| Revenue | €1.65b |
| Cost of Revenue | €679.57m |
| Gross Profit | €967.21m |
| Expenses | €730.94m |
| Earnings | €236.28m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Feb 11, 2022
| Earnings per share (EPS) | 2.64 |
| Gross Margin | 58.73% |
| Net Profit Margin | 14.35% |
| Debt/Equity Ratio | 0% |
How did AFX perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield34%
Payout RatioDoes AFX pay a reliable dividends?
See AFX dividend history and benchmarks| Carl Zeiss Meditec dividend dates | |
|---|---|
| Ex Dividend Date | Mar 31 2022 |
| Dividend Pay Date | Apr 04 2022 |
| Days until Ex dividend | 67 days |
| Days until Dividend pay date | 71 days |
Does AFX pay a reliable dividends?
See AFX dividend history and benchmarksValuation
Is Carl Zeiss Meditec undervalued compared to its fair value and its price relative to the market?
53.77x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: AFX (€142.05) is trading above our estimate of fair value (€114.6)
Significantly Below Fair Value: AFX is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: AFX is poor value based on its PE Ratio (53.8x) compared to the German Medical Equipment industry average (26.8x).
PE vs Market: AFX is poor value based on its PE Ratio (53.8x) compared to the German market (20.7x).
Price to Earnings Growth Ratio
PEG Ratio: AFX is poor value based on its PEG Ratio (5.7x)
Price to Book Ratio
PB vs Industry: AFX is overvalued based on its PB Ratio (7.7x) compared to the DE Medical Equipment industry average (4.3x).
Future Growth
How is Carl Zeiss Meditec forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
9.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AFX's forecast earnings growth (9.5% per year) is above the savings rate (-0.01%).
Earnings vs Market: AFX's earnings (9.5% per year) are forecast to grow slower than the German market (10.7% per year).
High Growth Earnings: AFX's earnings are forecast to grow, but not significantly.
Revenue vs Market: AFX's revenue (8% per year) is forecast to grow faster than the German market (5.7% per year).
High Growth Revenue: AFX's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AFX's Return on Equity is forecast to be low in 3 years time (14.7%).
Past Performance
How has Carl Zeiss Meditec performed over the past 5 years?
11.5%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AFX has high quality earnings.
Growing Profit Margin: AFX's current net profit margins (14.3%) are higher than last year (9.2%).
Past Earnings Growth Analysis
Earnings Trend: AFX's earnings have grown by 11.5% per year over the past 5 years.
Accelerating Growth: AFX's earnings growth over the past year (93.1%) exceeds its 5-year average (11.5% per year).
Earnings vs Industry: AFX earnings growth over the past year (93.1%) exceeded the Medical Equipment industry 76.9%.
Return on Equity
High ROE: AFX's Return on Equity (14.2%) is considered low.
Financial Health
How is Carl Zeiss Meditec's financial position?
Financial Position Analysis
Short Term Liabilities: AFX's short term assets (€1.6B) exceed its short term liabilities (€448.1M).
Long Term Liabilities: AFX's short term assets (€1.6B) exceed its long term liabilities (€270.5M).
Debt to Equity History and Analysis
Debt Level: AFX is debt free.
Reducing Debt: AFX had no debt 5 years ago.
Debt Coverage: AFX has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: AFX has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Carl Zeiss Meditec current dividend yield, its reliability and sustainability?
0.63%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: AFX's dividend (0.63%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1%).
High Dividend: AFX's dividend (0.63%) is low compared to the top 25% of dividend payers in the German market (3.33%).
Stability and Growth of Payments
Stable Dividend: AFX's dividends per share have been stable in the past 10 years.
Growing Dividend: AFX's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (34.1%), AFX's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: AFX's dividends in 3 years are forecast to be well covered by earnings (36.4% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.3yrs
Average management tenure
CEO
Carl Zeiss Meditec has no CEO, or we have no data on them.
Leadership Team
Experienced Management: AFX's management team is considered experienced (3.3 years average tenure).
Board Members
Experienced Board: AFX's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Carl Zeiss Meditec AG's employee growth, exchange listings and data sources
Key Information
- Name: Carl Zeiss Meditec AG
- Ticker: AFX
- Exchange: XTRA
- Founded: 1846
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: €12.705b
- Shares outstanding: 89.44m
- Website: https://www.zeiss.de/meditec-ag/home.html
Number of Employees
Location
- Carl Zeiss Meditec AG
- Goschwitzer Strasse 51-52
- Jena
- Thuringia
- 7745
- Germany
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/01/21 21:19 |
| End of Day Share Price | 2022/01/21 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2021/09/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.